By annette
The Swedish Institute for Health Economics (IHE) and the Bengt Jönsson Foundation for Health Economics Research are hereby pleased to announce the recipient of the scholarship for this year’s student thesis in health economics. Recipient of this year’s scholarship is Thomas Lane for his thesis “Do Price Increases Actually Prevent Generic Pharmaceutical Supply Issues Like …
By annette
What would happen if European countries extended breast cancer screening to women aged 45 to 74 and increased participation to 75%?
By annette
What are the main challenges with cervical cancer in Hong Kong and what should policymakers do? Our policy brief provides a comprehensive overview of the current situation along with high-level recommendations. The policy brief builds on targeted literature searches and interviews with local experts. For more information, please contact Thomas Hofmarcher
By annette
How does Costa Rica perform in cancer care compared with national targets and Latin American OECD peers? This dashboard-style report provides a visual and quantitative overview of selected performance indicators across governance, cancer burden, economic burden, prevention, early detection, diagnosis and coordinated care, and access to innovative medicines. The analysis draws on both national and …
By annette
Ovarian cancer remains one of the most challenging cancers, with rather low survival outcomes and it being the deadliest gynecologic cancer type in Western countries. IHE has developed a new fact sheet providing a concise overview of ovarian cancer, covering disease burden, economic impact, prevention, detection, diagnosis, treatment innovation, quality of life, and policy priorities. …
By annette
Swedish cancer care is undergoing a paradigm shift, driven by rising number of new cancer cases, improved survival rates and advances in medical technology, creating new demands on healthcare capacity, workforce sustainability and long-term planning. In this report, we examine the challenges that Swedish cancer care faces as patterns of care demand continue to change.
By annette
Study on the cost savings and quality-of-life gains associated with the use of an AI-powered digital tool for self-management of chronic pain has recently been published in Pain Medicine.
By annette
As part of IHE’s work on cancer policy, Andrea Manzano recently visited the Dominican Republic to present IHE’s policy brief on cervical cancer in the country during May 25–29. The visit provided an important opportunity to share the findings of the brief across several key settings and to engage in discussions on how cervical cancer …
By annette
On the sidelines of the 79th World Health Assembly in Geneva last week, IHE contributed to two important discussions on how evidence, data, and accountability can support measurable progress in global health. Together with the Lung Cancer Policy Network and MSD, IHE hosted the workshop “Operationalizing the Lung Cancer Agenda: A Pathway to Measurable Progress.” …
By annette
with a poster titled “Perspective Mismatch and Static Assumptions: Re-Thinking How Drug Prices Are Specified in U.S. Economic Analyses The U.S. Second Panel on Cost-Effectiveness and the ISPOR Drug Cost Task Force recommend that prices in economic evaluations reflect stakeholder “opportunity costs”. In practice, this is frequently violated: (1) price metrics often fail to reflect …